- Visibility 101 Views
- Downloads 79 Downloads
- Permissions
- DOI 10.18231/pjms.v.15.i.2.330-336
-
CrossMark
- Citation
Clinical insights of H1N1 and H3N2 influenza viruses: A study from the Kalyana-Karnataka region
- Author Details:
-
Vaibhav C Padashetti *
-
Abhishek Malipatil
-
Sai Pavan IN
-
Chethan Kumar BP
-
Shashidhar Mugali
-
Shilpa Malipatil
-
Prakash Hadimani
Background: Influenza viruses, particularly H1N1 and H3N2 variants, present significant public health challenges worldwide due to their potential to cause severe respiratory illnesses.
Aim and Objective: To investigate the clinical characteristics, prevalence, and treatment outcomes of confirmed H1N1 and H3N2 infections in patients from multiple tertiary care hospitals in Kalyana, Karnataka, during August to October 2023.
Materials and Methods: This study enrolled 11 patients with confirmed influenza infections. Demographic data, clinical presentations, underlying health conditions, treatment regimens, and outcomes were collected and analyzed.
Results: The median age of patients was 48 years. Diabetes mellitus was the most prevalent risk factor, affecting 64% of the cohort. The predominant symptoms included fever with chills (81%), cough (63%), and respiratory distress. Laboratory tests confirmed 8 patients (72%) with H1N1 and 3 patients (27%) with H3N2. The majority of patients (82%) required ICU admission, with a mean length of stay of 4.5 days. Complications observed included septic shock, respiratory failure, and multiorgan dysfunction. One patient ultimately succumbed to the illness.
Conclusion: This research highlights the critical need for vigilant monitoring and prompt treatment of influenza infections to reduce the risk of severe health complications. The findings emphasize the importance of public health measures and preparedness in managing seasonal influenza outbreaks, particularly in vulnerable populations.
References
- Zarogoulidis P, Constantinidis T, Steiropoulos P, Papanas N, Zarogoulidis K, Maltezos E. “Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?”. BMC Res Notes. 2011;1(1):4.
- Zarogoulidis P, Kouliatsis G, Papanas N, et al. Long-term respiratory follow-up of H1N1 infection. Virol J. 2011;8:319.
- Zarogoulidis P, Glaros D, Kontakiotis T, Froudarakis M, Kioumis I, Kouroumichakis I, et al. Health costs from hospitalization with H1N1 infection during the 2009–2010 influenza pandemic compared with non-H1N1 respiratory infections. Int J Gen Med. 2012;5:175–82.
- Shikov AN, Sementsova AO, Demina OK, et al. [Genetic variability of isolates of pandemic influenza A virus H1N1 isolated in Russia in 2009]. Mol Gen Mikrobiol Virusol. 2011;(4):23–29. 336 Padashetti et al / Panacea Journal of Medical Sciences 2025;15(2):330-336
- Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, Bolotin S, et al. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill. 2011;16(5):19784.
- Ravert RD, Fu LY, Zimet GD. Reasons for low pandemic H1N1 2009 vaccine acceptance within a college sample. Adv Prev Med. 2012;2012:242518.
- Cusumano-Towner M, Li DY, Tuo S, Krishnan G, Maslove DM. A social network of hospital acquired infection built from electronic medical record data. J Am Med Inform Assoc. 2013;20(3):427–34.
- Park S, Kim JI, Lee I, Lee S, Hwang MW, Bae JY. et al. Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009–2011. J Microbiol. 2012;50(6):1067–70.
- Chan KH, Chan KM, Ho YL, Tong HL, Poon LLM, Cowling BJ, et al. Quantitative analysis of four rapid antigen assays for detection of pandemic H1N1 2009 compared with seasonal H1N1 and H3N2 influenza A viruses on nasopharyngeal aspirates from patients with influenza. J Virol Methods. 2012;186(1–2):184–8.
- Park SJ, Kang BK, Jeoung HY, Moon HJ, Hong M, Na W, et al. Complete genome sequence of a canine-origin H3N2 feline influenza virus isolated from domestic cats in South Korea. Genome Announc. 2013;1(2):e0025312.
- Wong KK, Greenbaum A, Moll ME, Lando J, Moore EL, Ganatra R, et al. Outbreak of influenza A (H3N2) variant virus infection among attendees of an agricultural fair, Pennsylvania, USA, 2011. Emerg Infect Dis. 2012;18(12):1937–44
- Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One. 2012;7(9):e45051.
- Skowronski DM, Moser FS, Janjua NZ, Davoudi B, English KM, Purych D, et al. H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions. PLoS One. 2013;8(1):e54015.
- Chan MC, Lee N, Ngai KL, Kioumis I, Trakada G, Spyratos D, et al. A “pre-seasonal” hospital outbreak of influenza pneumonia caused by the drift variant A/Victoria/361/2011-like H3N2 viruses, Hong Kong, 2011. J Clin Virol. 2013;56(3):219–25.
- Mason RJ, Slutsky A, Murray JF, Nadel JA, Gotway MB. Murray and Nadel’s Textbook of Respiratory Medicine. Elsevier Health Sciences. 2015
- Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351(9101):467–71.
- Woods CW, McClain MT, Chen M, Zaas AK, Nicholson BP, Varkey J, et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS One. 2013;8(1):e52198.
- Ivan FX, Tan KS, Phoon MC, Engelward BP, Welsch R, Rajapakse JC, et al. Neutrophils infected with highly virulent influenza H3N2 virus exhibit augmented early cell death and rapid induction of type I interferon signaling pathways. Genomics. 2013;101(2):101–12.
- Rezaei F, Mirshafiey A, Shahmahmoodi S, Shoja Z, Ghavami N, Mokhtari-Azad T. Influenza virus-like particle containing two different subtypes of hemagglutinin confers protection in mice against lethal challenge with A/PR8 (H1N1) and A/HK (H3N2) viruses. Iran Red Crescent Med J. 2013;15(1):75–82.
- Hurt AC, Deng YM, Ernest J, Caldwell N, Leang L, Iannello P, et al. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region. Euro Surveill. 2011;16(3):19770.
- Maurer-Stroh S, Lee RT, Eisenhaber F, Cui L, Phuah SP, Lin RT. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza a virus. PLoS Curr. 2010;2:RRN1162.
- Advisory Committee on Immunization Practices Prevention and control of influenza with vaccines: interim recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013. MMWR Morb Mortal Wkly Rep. 2013;62(18):356.
- Wiwanitkit V. Novel avian H7N9 influenza and its way to humans. J Formos Med Assoc. 2013;112(10):654.
How to Cite This Article
Vancouver
Padashetti VC, Malipatil A, IN SP, BP CK, Mugali S, Malipatil S, Hadimani P. Clinical insights of H1N1 and H3N2 influenza viruses: A study from the Kalyana-Karnataka region [Internet]. Panacea J Med Sci. 2025 [cited 2025 Oct 27];15(2):330-336. Available from: https://doi.org/10.18231/pjms.v.15.i.2.330-336
APA
Padashetti, V. C., Malipatil, A., IN, S. P., BP, C. K., Mugali, S., Malipatil, S., Hadimani, P. (2025). Clinical insights of H1N1 and H3N2 influenza viruses: A study from the Kalyana-Karnataka region. Panacea J Med Sci, 15(2), 330-336. https://doi.org/10.18231/pjms.v.15.i.2.330-336
MLA
Padashetti, Vaibhav C, Malipatil, Abhishek, IN, Sai Pavan, BP, Chethan Kumar, Mugali, Shashidhar, Malipatil, Shilpa, Hadimani, Prakash. "Clinical insights of H1N1 and H3N2 influenza viruses: A study from the Kalyana-Karnataka region." Panacea J Med Sci, vol. 15, no. 2, 2025, pp. 330-336. https://doi.org/10.18231/pjms.v.15.i.2.330-336
Chicago
Padashetti, V. C., Malipatil, A., IN, S. P., BP, C. K., Mugali, S., Malipatil, S., Hadimani, P.. "Clinical insights of H1N1 and H3N2 influenza viruses: A study from the Kalyana-Karnataka region." Panacea J Med Sci 15, no. 2 (2025): 330-336. https://doi.org/10.18231/pjms.v.15.i.2.330-336